Background: Smoking is a remarkable risk factor in inflammatory bowel disease (IBD), with negative effects on Crohn's disease (CD) and positive effects on ulcerative colitis (UC). This makes different changes in smoking behaviour after diagnosis between CD and UC likely. Changes in active smoking, cessation plans and passive smoking were studied in IBD patients. Methods: 820 IBD patients were sent a questionnaire on active and passive smoking, and cessation plans. A total of 675 (82%) patients (380 CD and 295 UC) responded. Results: More ever smoking UC patients stopped smoking before diagnosis than CD patients (63% vs 22%; p b 0.001), resulting in 30% former smokers at diagnosis in UC and 13% in CD (p b 0.001). The smoking cessation rates at and after diagnosis are equal between CD and UC. Half of the CD patients stopped smoking after diagnosis leading to less present smokers in CD than in a control population (26% (95% confidence interval: 21.1%-29.9%) vs 33%). For both CD (22% vs 35%; p = 0.044) and UC (24% vs 53%; p = 0.024) continuing smokers after diagnosis were less often higher educated than quitters. Cessation plans (89%), passive smoking in childhood and present passive smoking were not different between CD and UC patients. Conclusion: There are no differences in changes in smoking behaviour at and after diagnosis between CD and UC patients, suggesting a lack of knowledge in these patients about the link between their disease and smoking behaviour. However, CD patients seem less refractory to
smoking cessation than the general population. Therefore it is worthwhile putting energy in helping CD patients stop smoking. © 2009 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
Background
The chronic inflammatory bowel diseases (IBD) Crohn' disease (CD) and ulcerative colitis (UC) are characterized by relapsing inflammation of the gastrointestinal tract. They share many clinical features, but there are also important differences, like the disease location and histological features. Another remarkable difference is the inverse effect of smoking on CD and UC. CD patients are more likely to be smokers than their matched controls, suggesting that smoking is a risk factor for development of CD. [1] [2] [3] In contrast, UC patients are less likely to be smokers than controls, so smoking seems to protect against development of UC. [2] [3] [4] In addition to the effect of smoking on the development of CD and UC, smoking also plays an important role on the disease course of both diseases. In CD, smokers more often experience flare-up episodes, have an increased need for steroids and immunosuppressants, and earlier recurrence after surgery. [5] [6] [7] [8] [9] [10] [11] In UC, smokers experience less flare-up episodes, and need less often hospitalizations, steroids and surgery. [11] [12] [13] [14] [15] The unfavourable effects of smoking on the disease course of CD patients make it very desirable for this category to stop smoking. Consequently, reviews have focussed on smoking cessation in CD, 16, 17 but to the best of our knowledge there are no studies about long term changes in smoking behaviour in CD patients after diagnosis. Furthermore, since smoking has beneficial effects in UC, smoking cessation in UC patients could lead to an increase in bowel complaints resulting in smoking relapse. Summarizing, smoking cessation is beneficial for CD patients, but could lead to unfavourable effects in UC patients. If CD and UC patients are aware of this link between their disease and smoking behaviour, different changes in smoking behaviour after diagnosis between CD and UC patients are likely.
As for active smoking, there could also be a role for passive smoking in IBD. Passive smoking in childhood could be a risk factor for the development of IBD, but literature about this is scarce and inconclusive. Some studies showed that passive smoking in childhood was a risk factor for developing CD. 18, 19 A recent meta-analysis showed no effect of passive smoking in childhood on CD, although a subanalysis only based on effects of maternal smoking showed a positive association with CD (odds ratio 1.3 (95% confidence interval (CI): 1.1-1.6)). 20 In UC, a protective effect of passive smoking in childhood was suggested, 21 but this could not be confirmed in a metaanalysis. 20 Studies about present passive smoking in adult IBD patients are even scarcer, with one study that showed no difference in passive smoking habits between CD and UC patients, and between these patients and controls. 22 The aim of this study was to extensively explore active smoking behaviour and passive smoking in CD and UC patients in a Dutch university hospital population. For active smoking behaviour we focussed on changes after diagnosis of IBD and cessation plans. For passive smoking we studied differences in passive smoking in childhood and present passive smoking between CD and UC. We hypothesized that CD patients more often stop smoking and avoid passive smoking after diagnosis than UC patients, because CD patients become aware of the risks of smoking for their disease and/or UC patients experience more complaints after smoking cessation. Secondly, we hypothesize that CD patients are more often exposed to passive smoking in childhood than UC patients.
Materials and methods

Patient population
All IBD patients who visited the outpatient department of our hospital between January 1995 and October 2005, and had a known or incident diagnosis of CD or UC by defined criteria were included. 23 A total of 820 alive IBD patients were identified and received a detailed questionnaire about smoking behaviour. A total of 675 patients responded to the questionnaire (82%) and were included in this study. Of these 675 patients we extensively described disease characteristics and behaviour before. 15 Clinical characteristics including information about active smoking were obtained through analysis of the medical charts. Detailed information about active and passive smoking behaviour was obtained through a written questionnaire. We compared the present smoking behaviour of CD and UC patients with a general, age adjusted Dutch population from the StatLine databank of the Dutch central agency for statistics (Statistics Netherlands; http:// statline.cbs.nl). The methods used were discussed with the medical ethics committee and according to Dutch legislation there were no objections against it. A returned and refilled questionnaire was considered as an informed consent.
Characteristics and outcome variables
Patient characteristics recorded were gender, age at diagnosis (divided according to the Montreal-classification in below 16 years, between 17 and 40 years, and above 40 years), 24 and time of diagnosis. Time of diagnosis was the date of the first detection of inflammatory abnormalities by radiological, endoscopic or peroperative examinations. 23 The end of follow-up was October 2005, or the last date of clinical or outpatient visit for patients who were discharged or had withdrawn from outpatient control.
Questionnaire for smoking behaviour
The written and detailed questionnaire about smoking behaviour included questions about 1) whether the patient had ever been smoking and if so, number of years smoked and, if a former smoker, months after cessation; 2) product smoked and average amount smoked per day; 3) the influence of the diagnosis of IBD on smoking behaviour; 4) plans for smoking cessation; 25 5) willingness to participate in a free smoking cessation program; 6) passive smoking in childhood; 7) present passive smoking and 8) educational level. For studying passive smoking in childhood patients were asked whether he or she inhaled smoke from cigarette smokers at home being a child. For present passive smoking was asked how many times the patient was more than 1 h in a room with smoking persons (every day, a few times a week, once a week or never).
Definitions of active smoking behaviour
Smoking behaviour was determined at the time of diagnosis and at the time of completing the questionnaire (present smoking). At both time points patients were divided in smokers, former smokers and never smokers. For defining smoking behaviour at the time of diagnosis, we used the information about smoking behaviour and number of years smoked or number of months after smoking cessation, and the time of diagnosis from the medical chart. A smoker at diagnosis started smoking seven or more cigarettes per week at least 6 months before diagnosis, a former smoker quitted smoking at least 6 months before diagnosis and a never smoker had never smoked until 6 months before diagnosis. The average amount smoked per day was adjusted by product smoked. Smoking 1 cigar was considered equal to 4 cigarettes, as the average cigar contains 4 g of tobacco and a cigarette 1 g. 26 
Statistical analysis
Descriptive variables are presented as medians (interquartile range (IQR)) and categorical variables as frequencies with percentages. The data were analyzed using the Statistical Package for the Social Sciences program version 12.0 (SPSS Inc., Chicago, Illinois, USA). Frequencies were compared with the chi-square test and medians with the Mann-Whitney test. Differences are considered significant when p b 0.05. The 95% CI was calculated if appropriate.
Results
Patient characteristics and smoking behaviour at diagnosis
Of the 675 patients that responded to the questionnaire (82%), 380 (56%) were known with CD and 295 (44%) with UC (Table 1) . CD patients were younger at diagnosis, more often female and had a longer follow-up than UC patients. CD patients were more often smokers and UC patients were more often both former and never smokers at diagnosis. In a previous study we already confirmed the difference in active smoking behaviour at diagnosis between CD and UC patients, and between these patients and the general population, with 52% (95%CI: 47.1%-57.2%) smokers in CD, 41% smokers in the general population and 28% (95%CI: 22.7%-32.9%) smokers in UC. 15 
Active smoking after diagnosis and influence of the diagnosis on smoking behaviour
To study changes in active smoking behaviour after diagnosis in CD and UC, we explored the influence of the diagnosis on the smoking behaviour and the present smoking behaviour (Table 2) . We hypothesized that when CD patients are aware of the risks of smoking for their disease and/or UC patients experience more complaints during smoking cessation, than after diagnosis CD patients more often have stopped smoking than UC patients. First, ever smokers (smokers and former smokers) at diagnosis were asked about the influence of the diagnosis of IBD on their smoking behaviour. UC patients more often had already stopped smoking before the diagnosis than CD patient. Smoking cessation rate at diagnosis was not different between CD and UC patients, although CD patients more often reduced smoking after being diagnosed with the disease. Relatively more CD patients did not change their smoke behaviour at diagnosis than UC patients.
Next, present active smoking was studied. Presently CD patients are still more often smokers and UC patients are more often never smokers. Furthermore, the number of cigarettes smoked per day is higher in present CD smokers than UC smokers. We compared the number of smokers with an age adjusted control population, in which 35% were smokers in 2006. In both CD (26% (95%CI: 21.1%-29.9%)) and UC (10% (95%CI: 6.4%-13.3%)) the number of present smokers is lower. Considering the higher number of females in CD, we also adjusted the smoking behaviour of the controls to gender. This leads to 33% smokers, which is still higher than in CD patients. Finally, to study differences in smoking cessation rates after diagnosis between CD and UC patients, we analyzed whether smokers at diagnosis were presently still smoking. For this purpose we excluded the smokers at diagnosis who stopped smoking within 1 year after diagnosis, because of our relatively rough measures of smoking behaviour at diagnosis. After this exclusion, 91 of the 179 (51%) CD patients and 38 of the 63 (60%) UC patients had stopped smoking after diagnosis. This difference is not significant (p = 0.195). In addition, differences between the continuing smokers and the smokers that stopped smoking after diagnosis were studied. For CD, the continuing smokers were more often lower (34% vs 21%; p = 0.047) and less often higher (22% vs 35%; p = 0.044) educated than quitters, and smoked less often cigarettes (53% vs 78%; p = 0.001) and cigars (1% vs 8%; p = 0.034) than quitters. For UC, the continuing smokers were less often higher educated (24% vs 53%; p = 0.024) than quitters and smoked fewer cigarettes per day (median (IQR): 10.0 (5.0-12.5) vs 12.5 (9.3-20.0); p = 0.005) than quitters. For both diseases no differences were found for gender, age at diagnosis, onset of disease and passive smoking in childhood.
Summarizing, UC patients more often stopped smoking before diagnosis and the cessation rate at diagnosis is similar. In contrast to our hypothesis, CD patients did not stop smoking more often after diagnosis than UC patients. However, still half of the CD patients have managed smoking cessation after diagnosis leading to a lower number of present smokers in CD than in a control population. In both CD and UC, a higher education is associated with smoking cessation after diagnosis.
Smoking cessation plans
To explore our hypothesis that CD patients are more willing to quit smoking compared to UC patients, we studied the smoking cessation plans and willingness to participate in a smoking cessation program for present smoking CD and UC patients (Table 3) . We could not confirm our hypothesis that there are differences between CD and UC patients in smoking cessation plans and willingness to join a group course for smoke cessation. However, for both diseases about 90% had the intention to stop smoking, although less than 30% wanted to join a free course for smoking cessation.
Passive smoking in childhood
To study the relation between passive smoking and the development of IBD, we explored differences in passive smoking in childhood between CD and UC. We studied this in all patients, in patients with onset of disease before 40 years and with onset of disease before 16 years (Fig. 1) . In all these groups passive smoking in childhood between CD and UC patients did not differ significantly.
Present passive smoking behaviour in non-smokers
Finally, we studied differences in present passive smoking between CD and UC. We studied this in present non-smokers (former and never smokers) to exclude a confounding effect of present active smoking. The present passive smoking in non-smoking CD and UC patients is shown in Fig. 2 , for both former and never smokers combined (non-smokers), and never smokers alone. In disagreement with our hypothesis that CD patients are aware of the risks of smoking for their disease and therefore more often avoid passive exposure to smoke than UC patients, we could not show significant differences in present passive smoking between CD and UC. 
Discussion
Smoking is a remarkable and well established risk factor in IBD, with negative effects on CD and positive effects on UC.
The inverse effects of smoking on CD and UC makes differences in changes in smoking behaviour after diagnosis between CD and UC likely, but hitherto no such information was available. Therefore, we extensively studied changes in active smoking, cessation plans and passive smoking in CD and UC patients in a large, Dutch university hospital population. The smoking cessation rate before diagnosis is higher in UC, but cessation rates at diagnosis and after diagnosis are equal between CD and UC. Half of the CD patients have managed smoking cessation after diagnosis leading to a lower number of present smokers in CD than in a control population. Cessation plans and willingness to join a cessation course are not different between CD and UC patients. Passive smoking in childhood and present passive smoking were studied, and both were not different between CD and UC.
In a previous analysis of this IBD population we already confirmed the difference in active smoking behaviour at diagnosis between CD and UC patients, and between these patients and a control population, with 52% (95%CI: 47%-57%) smokers in CD, 41% smokers in the controls and 28% (95% CI: 23%-33%) smokers in UC. 15 In the present analysis, it was shown that in ever smoking IBD patients, 63% of ever smoking UC patients stopped smoking before diagnosis compared to only 22% of CD patients, resulting in 30% former smoking patients in UC and 13% in CD at diagnosis. These numbers of former smokers are comparable with the numbers Aldhous et al. reported, although they defined former smokers as those who had stopped smoking 1 year or more before diagnosis instead of the 6 months in our study. 27, 28 This striking difference in former smokers between CD and UC is supportive for a causal relationship between smoking cessation and developing UC.
We hypothesized that CD patients more often stop smoking after diagnosis and avoid passive smoking after diagnosis than UC patients, because CD patients become aware of the risks of smoking for their disease and/or UC patients experience more complaints after smoking cessation. However, our results are in contradiction with this. First, more CD patients reported no influence of the diagnosis on smoking behaviour than UC patients (43% vs 22%) and smoking cessation at diagnosis was not different between CD and UC patients (14% vs 9%). Next, CD patients did not more often stop their smoking after diagnosis than UC patients (51% vs 60%) and CD patients did not more often avoid passive exposure to cigarette smoke. Finally, the present cessation plans are also not different between CD and UC patients; in both diseases about 35% have the intention to stop within 6 months. Not only are there no clear differences in changes in smoking behaviour between CD and UC patients, presently CD patients smoke more cigarettes per day than UC patients (12 vs 10).
Fortunately, there are also some positive findings in CD patients. First, CD patients more often reduced smoking at diagnosis than UC patients (18% vs 3%). Next, half of the CD patients have managed smoking cessation after diagnosis leading to a lower number of present smokers in CD than in the controls. Finally, in both diseases only 11% of the patients have no intention to stop smoking. This number is favourable compared to that in a group of 6260 healthy smokers from Australia, Canada, USA and UK in which 26% had no intention to stop smoking. 29 Therefore, both the intention to stop and the cessation rate in CD patients are better than in the general population. Thus, CD patients are less refractory to smoking cessation than the general population and therefore it is absolutely worthwhile to put energy in helping CD patients stop smoking. This is more or less in line with a previous study, that did not find evidence that smoking CD patients were overly refractory to smoking cessation. 30 Reviews that could be helpful in assisting CD patients with smoking cessation are available. 16, 17 Furthermore, it is important to keep in mind that CD patients could be less aware of the risks of smoking on their disease than we think, since studies showed an unawareness in CD patients of the association between smoking and their disease. 31, 32 Another issue to keep in mind is that level of education plays an important role in smoking cessation in the general population. 33, 34 We confirmed this in both CD and UC patients, since patients who succeeded in smoking cessation after diagnosis more often had completed higher education. Cosnes et al. showed that high socioeconomic status was a predictor of smoking cessation for more than 1 year in their intervention study. 35 In addition to changes in active smoking behaviour and present passive smoking, we also studied differences in passive smoking in childhood between CD and UC patients. Some studies have suggested that passive smoking in childhood could also have effects on the development of CD and UC, 18, 19, 21 but a recent meta-analysis showed no differences in passive smoking in childhood between both CD and UC, and controls. 20 Our findings of an equal rate in passive smoking in childhood between CD and UC patients are in line with this, although we did not include a control population. However, the effects of passive smoking in childhood could be dose-dependent 20, 36, 37 and therefore more studies are needed that analyze the effects of different levels of passive smoking in childhood on IBD.
It is important to note limitations of our study. Using a questionnaire may lead to selection bias, because it takes more time for smokers and/or former smokers to fill in the survey and they could be less willing to respond. However, the high response-rate to our questionnaire (82%) makes this unlikely. Asking about smoking behaviour in the past and the influence of the diagnosis of the disease on smoking behaviour could introduce a recall bias. The data on passive smoking in childhood was not confirmed by asking the parents of the patients. However, using a written questionnaire gives patients time to ask their parents about it.
In conclusion, we extensively studied changes in active smoking, cessation plans and passive smoking in CD and UC patients. The smoking cessation rate before diagnosis is higher in UC, but cessation rates at and after diagnosis are equal among CD and UC patients. In addition, there are no indications that CD patients avoid passive exposure to smoke more often. These findings suggest a lack of knowledge in CD and UC patients about the link between their disease and smoking behaviour, although our questionnaire did not address this knowledge in particular. However, half of the CD patients have managed smoking cessation after diagnosis leading to a lower number of present smokers in CD than in a control population, and many CD patients have cessation plans. So, CD patients are less refractory to smoking cessation than the general population and therefore it is worthwhile to put energy in helping CD patients stop smoking. In both CD and UC, a higher education is associated with smoking cessation after diagnosis. Finally, passive smoking in childhood was not different between CD and UC, but further research on this matter is needed.
